Prevalence and consequences of psoriasis in recent axial spondyloarthritis: an analysis of the DESIR cohort over 6 years
Main Authors: | Bruno Fautrel, Laure Gossec, Pascal Richette, Daniel Wendling, Florian Lucasson, Krystel Aouad, Adeline Ryussen-Witrand |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-01-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/8/1/e001986.full |
Similar Items
-
Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study
by: Maxime Dougados, et al.
Published: (2024-02-01) -
Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA)
by: Maxime Dougados, et al.
Published: (2023-03-01) -
Psoriasis seems often underdiagnosed in patient with axial spondyloarthritis
by: Angelique Rondags, et al.
Published: (2023-08-01) -
Difficult-to-treat axial spondyloarthritis is associated with psoriasis, peripheral involvement and comorbidities: results of an observational nationwide study
by: Daniel Wendling, et al.
Published: (2023-10-01) -
Längsschnittanalyse von Psoriasis, rheumatoider Arthritis, Psoriasis-Arthritis, axialer Spondyloarthritis und chronischen Darmerkrankungen
by: Priv.-Doz. Dr. med. Hildrun Haibel, et al.
Published: (2023-04-01)